These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 202978)

  • 1. Epstein-Barr virus infection of cryopreserved umbilical cord blood lymphocytes.
    Shope TC; Sell MK; Smith ST; Peterson WD; Stulberg CS
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):326-9. PubMed ID: 202978
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformation in the presence of dimethyl sulfoxide facilitates recovery of Epstein-Barr virus.
    Wilson GL
    Intervirology; 1983; 19(1):56-60. PubMed ID: 6298146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.
    Robinson J; Frank A; Henderson E; Schweitzer J; Miller G
    Infect Immun; 1979 Oct; 26(1):225-31. PubMed ID: 227794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of hypomethylated Epstein-Barr viral DNA is stimulated by dimethylsulfoxide treatment of lymphoblastoid cells.
    Larocca D; Homisak D; Clough W
    Biochem Biophys Res Commun; 1981 May; 100(2):559-65. PubMed ID: 6268064
    [No Abstract]   [Full Text] [Related]  

  • 5. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.
    Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D
    J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus.
    Katsuki T; Hinuma Y; Yamamoto N; Abo T; Kumagai K
    Virology; 1977 Dec; 83(2):287-94. PubMed ID: 201086
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated fatty acids confer cryoresistance on megakaryocytes generated from cord blood and also enhance megakaryocyte production from cryopreserved cord blood cells.
    Shabrani NC; Khan NF; Kale VP; Limaye LS
    Cytotherapy; 2012 Mar; 14(3):366-80. PubMed ID: 22250991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes.
    Louie LG; King MC
    Am J Hum Genet; 1991 Mar; 48(3):637-8. PubMed ID: 1847792
    [No Abstract]   [Full Text] [Related]  

  • 10. Indefinite and temporary growths of human cord lymphocytes in vitro by Epstein-Barr virus.
    Osato T; Aya T; Mizuno F
    Bibl Haematol; 1975 Oct; (43):302-7. PubMed ID: 183688
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of n-butyrate on transformation of human lymphocytes by Epstein-Barr virus.
    Roubalová K; Roubal J
    Intervirology; 1985; 23(1):51-4. PubMed ID: 2982760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample age and Epstein-Barr virus transformation of cryopreserved lymphocytes.
    Reidy JA; Wheeler VA
    In Vitro Cell Dev Biol; 1992 Jun; 28A(6):383-4. PubMed ID: 1321805
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D; Margalith M
    Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line.
    Ragona G; Ernberg I; Klein G
    Virology; 1980 Mar; 101(2):553-7. PubMed ID: 6244705
    [No Abstract]   [Full Text] [Related]  

  • 15. Chinese and African Euphorbiaceae plant extracts: markedly enhancing effect on Epstein-Barr virus-induced transformation.
    Mizuno F; Koizumi S; Osato T; Kokwaro JO; Ito Y
    Cancer Lett; 1983 Jun; 19(2):199-205. PubMed ID: 6309363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Epstein-Barr virus transformation for the establishment of class II positive cord blood cells for use in analysis of maternal sera.
    Maurer DH; Baker K; Sumaya CV; Brown D; Callaway C; Pollack MS
    Tissue Antigens; 1986 Jul; 28(1):24-8. PubMed ID: 3018958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycolysis in native and cryopreserved lymphocytes].
    Gordienko AD; Tsuraeva AA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (12):26-8. PubMed ID: 6976800
    [No Abstract]   [Full Text] [Related]  

  • 18. Regeneration in vitro of previously frozen adult mouse and human striated muscle coupled with fetal spinal cord.
    Liveson JA; Peterson ER; Crain SM; Borstein MB
    Exp Neurol; 1975 Sep; 48(3 Pt 1):624-36. PubMed ID: 1175719
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.
    Thorley-Lawson DA; Chess L; Strominger JL
    J Exp Med; 1977 Aug; 146(2):495-508. PubMed ID: 195004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three phases in transformation of human lymphocytes by Epstein-Barr virus, as revealed by colony formation in soft agar.
    Harada S; Katsuki T; Hinuma Y
    Microbiol Immunol; 1981; 25(1):23-9. PubMed ID: 6265738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.